Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia

Meghali Goswami, Gege Gui, Laura W. Dillon, Katherine E. Lindblad, Julie Thompson, Janet Valdez, Dong Yun Kim, Jack Y. Ghannam, Karolyn A. Oetjen, Christin B. Destefano, Dana M. Smith, Hanna Tekleab, Yeusheng Li, Pradeep Dagur, Thomas Hughes, Jennifer L. Marté, Jaydira Del Rivero, Joanna Klubo-Gwiezdzinksa, James L. Gulley, Katherine R. CalvoCatherine Lai, Christopher S. Hourigan*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

40 Scopus citations

Fingerprint

Dive into the research topics of 'Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences